1. Home
  2. STVN vs PEGA Comparison

STVN vs PEGA Comparison

Compare STVN & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • PEGA
  • Stock Information
  • Founded
  • STVN 1949
  • PEGA 1983
  • Country
  • STVN Italy
  • PEGA United States
  • Employees
  • STVN N/A
  • PEGA N/A
  • Industry
  • STVN Containers/Packaging
  • PEGA EDP Services
  • Sector
  • STVN Consumer Discretionary
  • PEGA Technology
  • Exchange
  • STVN Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • STVN 5.7B
  • PEGA 6.3B
  • IPO Year
  • STVN 2021
  • PEGA 1996
  • Fundamental
  • Price
  • STVN $20.93
  • PEGA $72.21
  • Analyst Decision
  • STVN Buy
  • PEGA Buy
  • Analyst Count
  • STVN 7
  • PEGA 12
  • Target Price
  • STVN $26.93
  • PEGA $100.17
  • AVG Volume (30 Days)
  • STVN 372.3K
  • PEGA 877.7K
  • Earning Date
  • STVN 03-06-2025
  • PEGA 04-23-2025
  • Dividend Yield
  • STVN 0.28%
  • PEGA 0.17%
  • EPS Growth
  • STVN N/A
  • PEGA 50.76
  • EPS
  • STVN 0.45
  • PEGA 1.11
  • Revenue
  • STVN $1,143,012,735.00
  • PEGA $1,497,180,000.00
  • Revenue This Year
  • STVN $8.60
  • PEGA $8.60
  • Revenue Next Year
  • STVN $12.43
  • PEGA $6.89
  • P/E Ratio
  • STVN $46.99
  • PEGA $65.29
  • Revenue Growth
  • STVN 1.72
  • PEGA 4.51
  • 52 Week Low
  • STVN $16.56
  • PEGA $54.55
  • 52 Week High
  • STVN $31.61
  • PEGA $113.67
  • Technical
  • Relative Strength Index (RSI)
  • STVN 50.35
  • PEGA 37.23
  • Support Level
  • STVN $20.11
  • PEGA $67.03
  • Resistance Level
  • STVN $21.21
  • PEGA $76.68
  • Average True Range (ATR)
  • STVN 1.00
  • PEGA 2.10
  • MACD
  • STVN -0.05
  • PEGA 0.53
  • Stochastic Oscillator
  • STVN 35.51
  • PEGA 32.64

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

Share on Social Networks: